AHRR (cg05575921) hypomethylation marks smoking behaviour, morbidity and mortality

Thorax

Volumn 72, Issue 7, 2017, Pages 646-653

  Bojesen, Stig E ^a,b,c   Timpson, Nicholas ^d   Relton, Caroline ^d   Davey Smith, George ^d   Nordestgaard, Børge G ^a,b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

COPD epidemiology; Lung Cancer; Tobacco and the lung

Indexed keywords

AHRR PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BIOLOGICAL MARKER; CHRNA1 PROTEIN, HUMAN; NICOTINIC RECEPTOR; REPRESSOR PROTEIN;

ADVERSE EFFECTS; AGED; CAUSE OF DEATH; DENMARK; DIAGNOSTIC IMAGING; DISEASE COURSE; DNA METHYLATION; FEMALE; GENETICS; GENOTYPE; HIGH RISK BEHAVIOR; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SMOKING;

AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOMARKERS; CAUSE OF DEATH; DENMARK; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, NICOTINIC; REPRESSOR PROTEINS; RISK ASSESSMENT; RISK-TAKING; SMOKING;

EID: 85011021507     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-208789     Document Type: Article

References (33)

1. WHO Global Report. Mortality Attributable to Tobacco. 2012.
2. Wilcox RG, Hughes J, Roland J. Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J 1979;2:1026-8.
3. Shipton D, Tappin DM, Vadiveloo T, et al. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: A retrospective, cross sectional study. BMJ 2009;339:b4347.
4. Djordjevic MV, Stellman SD, Zang E. Doses of nicotine and lung carcinogens delivered to cigarette smokers. J Natl Cancer Inst 2000;92:106-11.
5. St Charles FK, McAughey J, Shepperd CJ. Methodologies for the quantitative estimation of toxicant dose to cigarette smokers using physical, chemical and bioanalytical data. Inhal Toxicol 2013;25:383-97.
6. Munafo MR, Timofeeva MN, Morris RW, et al. Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. J Natl Cancer Inst 2012;104:740-8.
7. Coleman T, Cooper S, Thornton JG, et al. A randomized trial of nicotinereplacement therapy patches in pregnancy. N Engl J Med 2012;366:808-18.
8. Ussher M, Lewis S, Aveyard P, et al. Physical activity for smoking cessation in pregnancy: randomised controlled trial. BMJ 2015;350:h2145.
9. Zeilinger S, Kuhnel B, Klopp N, et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One 2013;8:e63812.
10. Philibert RA, Beach SR, Brody GH. Demethylation of the aryl hydrocarbon receptor repressor as a biomarker for nascent smokers. Epigenetics 2012;7:1331-8.
11. Philibert RA, Beach SR, Lei MK, et al. Changes in DNA methylation at the aryl hydrocarbon receptor repressor May be a new biomarker for smoking. Clin Epigenetics 2013;5:19.
12. Shenker NS, van Polidoro S, et al Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet 2013;22:843-51.
13. Dogan MV, Shields B, Cutrona C, et al. The effect of smoking on DNA methylation of peripheral blood mononuclear cells from African American women. BMC Genomics 2014;15:151.
14. Wu HC, Wang Q, Chung WK, et al. Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY Girls study. Epigenetics 2014;9:929-33.
15. Elliott HR, Tillin T, McArdle WL, et al. Differences in smoking associated DNA methylation patterns in South Asians and Europeans. Clin Epigenetics 2014;6:4.
16. Gao X, Jia M, Zhang Y, et al. DNA methylation changes of whole blood cells in response to active smoking exposure in adults: A systematic review of DNA methylation studies. Clin Epigenetics 2015;7:113.
17. Philibert R, Hollenbeck N, Andersen E, et al. Reversion of AHRR demethylation is a quantitative biomarker of smoking cessation. Front Psychiatry 2016;7:55.
18. Zhang Y, Yang R, Burwinkel B, et al. F2RL3 methylation in blood DNA is a strong predictor of mortality. Int J Epidemiol 2014;43:1215-25.
19. Zhang Y, Schottker B, Ordonez-Mena J, et al. F2RL3 methylation, lung cancer incidence and mortality. Int J Cancer 2015;137:1739-48.
20. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
21. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-54.
22. Tammemagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-36.
23. Dahl M, Tybjaerg-Hansen A, Lange P, et al. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann Intern Med 2002;136:270-9.
24. Kaur-Knudsen D, Bojesen SE, Tybjaerg-Hansen A, et al. Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: A cohort study. J Clin Oncol 2011;29:2875-82.
25. Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013;309:2353-61.
26. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
27. Irizarry RA, Ladd-Acosta C, Carvalho B, et al. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res 2008;18:780-90.
28. Fasanelli F, Baglietto L, Ponzi E, et al. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. Nat Commun 2015;6:10192.
29. Haarmann-Stemmann T, Abel J. The arylhydrocarbon receptor repressor (AhRR): structure, expression, and function. Biol Chem 2006;387:1195-9.
30. Monick MM, Beach SR, Plume J, et al. Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers. Am J Med Genet B Neuropsychiatr Genet 2012;159B:141-51.
31. Zudaire E, Cuesta N, Murty V, et al. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. J Clin Invest 2008;118:640-50.
32. Richmond RC, Simpkin AJ, Woodward G, et al. Prenatal exposure to maternal smoking and offspring DNA methylation across the lifecourse: findings from the Avon Longitudinal Study of Parents and Children (ALSPAC). Hum Mol Genet 2015;24:2201-17.
33. Terry MB, Delgado-Cruzata L, Vin-Raviv N, et al. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011;6:828-37.